Damian McNamara
News
Lilly stops antibody trial in hospitalized COVID-19 patients, other trials continue
October 28, 2020
Eli Lilly announced it will halt its ACTIV-3 trial evaluating the antibody bamlanivimab in combination with remdesivir for people hospitalized with COVID-19.
![1]()
News
Trump and Biden face off over COVID-19, ACA in final debate
October 23, 2020
The adequacy of the COVID-19 response to date, the likely timeline for vaccine availability, and how to reopen businesses were among the points on which the two candidates disagreed.
![1]()
News
CDC expands definition of COVID-19 exposure from ‘close contact’
October 23, 2020
Four factors associated with higher risk for transmission are the proximity of each encounter, its duration, whether an interaction takes place indoors or outdoors, and the number of people encountered.
![1]()
News
Rinse and repeat? Mouthwash might mitigate COVID-19 spread
October 22, 2020
"I would recommend the use of the rinses on top of wearing mask and social distancing. This could add a layer of protection for yourself and others."
News
‘Profound human toll’ in excess deaths from COVID-19 calculated in two studies
October 13, 2020
The number of deaths caused by the pandemic exceeds publicly reported COVID-19 death counts by 20%.
News
Three major COVID vaccine developers release detailed trial protocols
September 23, 2020
Typically, manufacturers guard the specifics of preclinical vaccine trials. This rare move follows calls for greater transparency.
News
Infectious COVID-19 can persist in gut for weeks
September 14, 2020
“We found active and prolonged SARS-CoV-2 infection in the stool of patients with COVID-19, even after recovery, suggesting that coronavirus could remain in the gut of asymptomatic carriers.”
News
Unexpected results in new COVID-19 ‘cytokine storm’ data
September 9, 2020
Circulating cytokine concentrations are lower in patients with COVID-19, compared with other diseases.
News
High mortality rates reported in large COVID-19 study
September 2, 2020
“What I found most illuminating was this whole concept of comorbid conditions. This provides suggestive data about who we need to worry about most and who we may need to worry about less.”
![1]()
News
FDA approves point-of-care COVID-19 antigen test
August 27, 2020
“This new COVID-19 antigen test is an important addition to available tests because the results can be read in minutes, right off the testing card.”
